Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 6/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28945492 | 0.73 | TSHR (0.35) | ALDH1A1TSHRTRPA1CA4LMNA | |
| SCHEMBL1402206 | 0.71 | MAPT (0.37) | ALDH1A1TSHRDPP4F2HTR2A | |
| SCHEMBL26674 | 0.69 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1CA1CA2 | |
| SCHEMBL28748541 | 0.69 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1CA1CA2 | |
| SCHEMBL5028588 | 0.69 | ALDH1A1 (0.40) | ALDH1A1TSHRHTR2AHRH1TDP1 | |
| SCHEMBL11176427 | 0.67 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL126345 | 0.67 | CA4 (0.41) | ALDH1A1TSHRTRPA1TDP1CA1 | |
| SCHEMBL2511520 | 0.67 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1CA1CA2 | |
| SCHEMBL8881696 | 0.67 | ALDH1A1 (0.38) | ALDH1A1TSHRTRPA1TDP1CA1 | |
| Phosphine SCHEMBL20701190 | 0.67 | ALDH1A1 (0.38) | ALDH1A1TSHRTDP1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1301672-A | — | — | None | — | — | JP | disclosed |
| EP-4290637-A1 | METAL M-AIR BATTERY CELL COMPRISING AN ORGANIC MULTI REDOX MEDIATOR COMPOUND AS SOLUBLE ORGANIC CATALYST | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-109627162-B | Process for preparing (7E) -7, 9-decanedioic acid esters | 信越化学工业株式会社 | 2022-11-15 | — | — | CN | disclosed |
| CN-109219612-A | Prepare 17 (20)-alkene B- open loop steroids method and intermediate | 帕西昂奥地利有限两合公司 | 2019-01-15 | — | — | CN | disclosed |
| US-9463187-B2 | Methylphenidate derivatives and uses of them | AMPIO PHARMACEUTICALS, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| CN-103842396-B | Active energy ray-curable resin composition, method for producing same, coating material, coating film, and film | DIC CORP. (JP) | 2016-03-16 | — | — | CN | disclosed |
| CN-102827087-B | Synthetic method of erlotinib | CHENGDU INST BIOLOGY CAS | 2015-03-25 | — | — | CN | disclosed |
| CN-103842396-A | Active energy ray-curable resin composition, method for producing same, coating material, coating film, and film | DAINIPPON INK & CHEMICALS | 2014-06-04 | — | — | CN | disclosed |
| CN-102827087-A | Synthetic method of erlotinib | CHENGDU INST BIOLOGY CAS | 2012-12-19 | — | — | CN | disclosed |
| US-20120101129-A1 | Methylphenidate Derivatives and Uses of Them | AMPIO PHARMACEUTICALS, INC. | 2012-04-26 | — | — | US | disclosed |
| CN-1092409-A | The compound that is used for the treatment of leukotriene-related disease | SMITHKLINE BEECHAM CORP (US) | 1994-09-21 | — | — | CN | disclosed |
| CN-1073431-A | The compound that is used for the treatment of leukotriene-related disease | SMITHRLINE BEECHAM CORP (US) | 1993-06-23 | — | — | CN | disclosed |
| US-5011739-A | Moisture stable biasable transfer members and method for making same | EASTMAN KODAK COMPANY (US) | 1991-04-30 | — | — | US | disclosed |
| EP-0421299-A2 | Moisture stable biasable transfer members and method for making same | EASTMAN KODAK COMPANY (US) | 1991-04-10 | — | — | EP | disclosed |
| JP-H01301672-A | SPIROOCTAHYDRONAPHTHALENES, NOVEL INTERMEDIATE THEREOF AND PRODUCTION OF SAID NAPHTHALENES AND INTERMEDIATE | T HASEGAWA CO LTD | 1989-12-05 | — | — | JP | disclosed |
| EP-0227472-B1 | 10 BETA-ALKYNYLESTRENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FARMITALIA CARLO ERBA S.r.l. (IT) | 1989-10-18 | — | — | EP | disclosed |
| US-4808578-A | ANTICARCINOGENIC AGENTS | FARMITALIA CARLO ERBA S. R. L. (IT) | 1989-02-28 | — | — | US | disclosed |
| EP-0227472-A1 | 10 Beta-alkynylestrene derivatives and process for their preparation | FARMITALIA CARLO ERBA S.r.l. (IT) | 1987-07-01 | — | — | EP | disclosed |
| US-4661590-A | BACTERICIDES | BRISTOL-MYERS COMPANY (US) | 1987-04-28 | — | — | US | disclosed |
| US-4520022-A | BACTERIAL INFECTION IN MAMMALS | BRISTOL-MYERS COMPANY (US) | 1985-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101129-A1 | Methylphenidate Derivatives and Uses of Them | SLC6A3, COMT, UGT1A1 | ALDH1A1 335/4885TSHR 827/4885DPP4 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.